Abstract
Background Elimination and prevention of mother to child human immunodeficiency virus (HIV) transmission remains a global public health concern. Identification of significant risk factors of mother to child transmission is essential in reducing the burden of pediatric HIV in terms of cost of treatment, morbidity and mortality. Only a few studies have been done to demonstrate the importance of Prevention of Mother to Child Transmission (PMTCT) cascade, including the indicators and how missing one of the crucial steps of the cascade could increase the risk of infant HIV transmission. This study seeks to determine maternal risk factors related to HIV transmission among children born to HIV-infected mothers enrolled in PMTCT program in Kilifi County between July 2018 and June 2019.
Methods This was a retrospective unmatched case control study. Systematic random sampling was used to select medical records of 183 exposed infants (61 cases and 122 controls). A structured tool was used to collect data. Proportions and frequency distribution was done in univariate analysis and in bivariate analysis, chi-square and logistic regression (odds ratio) was used to determine any association and strength of association between categorical variables.
Results Receiving maternal HAART in ANC was established as the major determinant of a favorable HEI outcome in this study. Infants whose mothers had received maternal HAART in ANC were 52.55 (14.89 - 185.48) times more likely to be HIV negative compared to those whose mothers did not receive maternal HAART in ANC. Disclosure of HIV status by the mother at ANC was 3.18 (1.28 - 7.90) times more likely to determine a favorable outcome of the HEI compared to non-disclosure. When adjusted for other factors, it was 6.27 (1.20 - 20.05) times more likely to determine a favorable outcome.
Conclusion The study established the importance of PMTCT service delivery in reduction of vertical transmission of HIV. Women who defaulted on the PMTCT cascade services had higher odds of having a HIV positive infant compared to women who accessed all the PMTCT services at the recommended time.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
KNH-UON Ethics and Research Committee
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
